Mowery & Schoenfeld Wealth Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$584K Hold
1,511
0.8% 25
2026
Q1
$442K Hold
1,511
0.68% 31
2025
Q4
$530K Hold
1,511
0.77% 28
2025
Q3
$488K Hold
1,511
0.84% 25
2025
Q2
$588K Hold
1,511
0.89% 20
2025
Q1
$657K Sell
1,511
-33
-2% -$13.2K 1.29% 16
2024
Q4
$570K Buy
1,544
+33
+2% +$13.8K 1.11% 19
2024
Q3
$786K Hold
1,511
1.24% 14
2024
Q2
$819K Hold
1,511
1.18% 15
2024
Q1
$784K Hold
1,511
1.51% 14
2023
Q4
$713K Buy
+1,511
New +$699K 1.44% 15

Other funds holding ELV

Mowery & Schoenfeld Wealth Management's ELV Position: Q2 2026 in Review

Mowery & Schoenfeld Wealth Management held its Elevance Health (ELV) position steady in Q2 2026 at 1,511 shares worth $584K. The position accounts for 0.8% of the portfolio, ranked #25.

Mowery & Schoenfeld Wealth Management first reported a position in ELV in Q4 2023 and has held it in 11 quarters since. The position peaked at $819K in Q2 2024. 917 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Mowery & Schoenfeld Wealth Management held 1,511 shares of Elevance Health worth $584K as of Q2 2026.
  • Mowery & Schoenfeld Wealth Management left its Elevance Health share count unchanged in Q2 2026.
  • Elevance Health made up 0.8% of Mowery & Schoenfeld Wealth Management's portfolio in Q2 2026, its #25 holding.
  • Mowery & Schoenfeld Wealth Management first reported a position in Elevance Health in Q4 2023 and has held it in 11 quarters since.
  • Mowery & Schoenfeld Wealth Management's Elevance Health position peaked at $819K in Q2 2024.
  • 917 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Mowery & Schoenfeld Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.